Want to join the conversation?
$APD 3Q15 PR: Sales were $2,470.2MM, decreased 6% vs. prior year, as underlying sales growth of 4% was offset by unfavorable currency and lower energy pass-through. Volumes increased 3%, primarily in Industrial Gases–Asia, Materials Technologies and the LNG business, and pricing was up 1%. Net income was $318.8MM compared to $314MM in 3Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.